U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07422207) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants' on Feb. 04.
Brief Summary: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
BIOLOGICAL: ME3241
Part 1 (single ascending dose):
Participants will receive a single infusion of ME3241.
Part 2 (multiple ascending dose):
Participants will receive multiple infusions of ME3241.
Part 3 (single dose for Japanes...